HK Stock Market Move | INNOCARE (09969) opens over 13% higher, expecting a net profit of approximately 633 million yuan for the year 2025, marking the first time it has turned a loss into profit.

INNOCARE (09969) opened more than 13% higher, rising 13.6% to HK$13.2 as of press time, with a trading volume of HK$1099.56 million. On the news front, INNOCARE announced that according to preliminary calculations by the finance department, the company is expected to achieve total operating revenue of approximately RMB 2.365 billion in 2025, an increase of around 134% year-on-year. The company expects to achieve its first profit in 2025, with a net profit attributable to the owners of the parent company of approximately RMB 633 million, an increase of approximately RMB 1.074 billion year-on-year; the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses is expected to be approximately RMB 534 million, an increase of approximately RMB 974 million year-on-year. The change in performance is mainly due to the continued rapid growth of the company's drug revenue and the growth in business development (BD) revenue in the current year.